AIM: To examine the calcium metabolism of colorectal cancer (CRC) in patients with colorectal cancer and control patients. METHODS: Seventy newly diagnosed CRC patients were included. The healthy control group was age and gender matched (n=32). Particular attention was devoted to the relationship between serum calcium of patients, and levels of AFP, CEA, carbohydrate antigen 19-9 (CA 19-9) (that could be considered as prognostic factors). Furthermore, the Ca-sensing receptor (CaSR) gene A986S polymorphism was investigated in these patients, as well as the relationship between different CaSR genotypes and the data stated above. RESULTS: A lower level of ionized calcium (also corrected for albumin) was found in the serum of CRC patients with normal 25(OH) vitamin D levels. The ionized calcium concentration was inversely correlated with the serum level of CA 19-9. There was no difference in the distribution of CaSR genotypes, between CRC patients and general population. The genotypes did not correlate with other data examined. CONCLUSION: Based on these results, lower levels of serum calcium might be a pathogenic and prognostic factor in colorectal cancer.
AIM: To examine the calcium metabolism of colorectal cancer (CRC) in patients with colorectal cancer and control patients. METHODS: Seventy newly diagnosed CRCpatients were included. The healthy control group was age and gender matched (n=32). Particular attention was devoted to the relationship between serum calcium of patients, and levels of AFP, CEA, carbohydrate antigen 19-9 (CA 19-9) (that could be considered as prognostic factors). Furthermore, the Ca-sensing receptor (CaSR) gene A986S polymorphism was investigated in these patients, as well as the relationship between different CaSR genotypes and the data stated above. RESULTS: A lower level of ionizedcalcium (also corrected for albumin) was found in the serum of CRCpatients with normal 25(OH) vitamin D levels. The ionizedcalcium concentration was inversely correlated with the serum level of CA 19-9. There was no difference in the distribution of CaSR genotypes, between CRCpatients and general population. The genotypes did not correlate with other data examined. CONCLUSION: Based on these results, lower levels of serum calcium might be a pathogenic and prognostic factor in colorectal cancer.
Authors: S Osada; Y Hashimoto; S Nomura; Y Kohno; K Chida; O Tajima; K Kubo; K Akimoto; H Koizumi; Y Kitamura Journal: Cell Growth Differ Date: 1993-03
Authors: P R Holt; E O Atillasoy; J Gilman; J Guss; S F Moss; H Newmark; K Fan; K Yang; M Lipkin Journal: JAMA Date: 1998 Sep 23-30 Impact factor: 56.272
Authors: Paulo Freire; Francisco Portela; Maria M Donato; Pedro Figueiredo; Manuela Ferreira; Pedro Amaro; Anabela Sá; Paulo Andrade; Hermano Gouveia; Carlos Sofia Journal: Int J Colorectal Dis Date: 2010-07-30 Impact factor: 2.571
Authors: G Anton Decker; Mashal J Batheja; Joseph M Collins; Alvin C Silva; Kristin L Mekeel; Adyr A Moss; Cuong C Nguyen; Douglas F Lake; Laurence J Miller Journal: Gastroenterol Hepatol (N Y) Date: 2010-04
Authors: Elizabeth T Jacobs; Maria E Martínez; Peter T Campbell; David V Conti; David Duggan; Jane C Figueiredo; Robert W Haile; Elizabeth C LeRoy; Jenny N Poynter; Patricia A Thompson; John A Baron Journal: Carcinogenesis Date: 2010-06-17 Impact factor: 4.944
Authors: Linda M Dong; Cornelia M Ulrich; Li Hsu; David J Duggan; Debbie S Benitez; Emily White; Martha L Slattery; Bette J Caan; John D Potter; Ulrike Peters Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-10 Impact factor: 4.254